How to buy G Medical Innovations Holdings stock (G Medical Innovations Holdings Ltd)

G Medical Innovations was previously listed on the Australian Securities Exchange (ASX), but was voluntarily delisted. The company is now filing for an IPO in the US. Here's how to buy in when it goes public.

Our top picks for where to buy G Medical Innovations Holdings Ltd stock

Buy G Medical Innovations Holdings stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

G Medical Innovations Holdings stock price (NASDAQ: GMVD)

Use our graph to track the performance of GMVD stocks over time.

G Medical Innovations Holdings shares at a glance

• Key figures

Information last updated 2023-12-17.

52-week range	$0.00 - $0.00
50-day moving average more info button	$0.24
200-day moving average more info button	$1.43
Wall St. target price	$4.00
PE ratio more info button	N/A
Dividend yield more info button	$0 (0%)
Earnings per share (TTM) more info button	$-18.76

Is it a good time to buy G Medical Innovations Holdings stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

G Medical Innovations Holdings financials

Revenue TTM	$4.4 million
Gross profit TTM	$1.5 million
Return on assets TTM	-223.33%
Return on equity TTM	-865.21%
Profit margin	0%
Book value	$-4.82
Market Capitalization more info button	$1.8 million

TTM: trailing 12 months

G Medical Innovations Holdings share dividends

We're not expecting G Medical Innovations Holdings to pay a dividend over the next 12 months.

You may also wish to consider:

Have G Medical Innovations Holdings's shares ever split?

G Medical Innovations Holdings's shares were split on a 1:35 basis on 20 November 2022 . So if you had owned 35 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your G Medical Innovations Holdings shares – just the quantity. However, indirectly, the new 3400% higher share price could have impacted the market appetite for G Medical Innovations Holdings shares which in turn could have impacted G Medical Innovations Holdings's share price.

G Medical Innovations Holdings share price volatility

Over the last 12 months, G Medical Innovations Holdings's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while G Medical Innovations Holdings's is -1.0835. This would suggest that G Medical Innovations Holdings's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, G Medical Innovations Holdings has bucked the trend.

To put G Medical Innovations Holdings's beta into context you can compare it against those of similar companies.

• Heartbeam (BEAT.US): -0.987
• iRhythm Technologies (IRTC.US): 1.229
• Boston Scientific (BSX.US): 0.797

G Medical Innovations Holdings overview

G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The company's products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures ECG data continuously for up to 14 days. It develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, it offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. G Medical Innovations Holdings Ltd was incorporated in 2014 and is headquartered in Rehovot, Israel. .

Frequently asked questions

null
What percentage of G Medical Innovations Holdings is owned by insiders or institutions?
Currently 15.284% of G Medical Innovations Holdings shares are held by insiders and 16.918% by institutions. How many people work for G Medical Innovations Holdings?
Latest data suggests 84 work at G Medical Innovations Holdings. When does the fiscal year end for G Medical Innovations Holdings?
G Medical Innovations Holdings's fiscal year ends in December. Where is G Medical Innovations Holdings based?
G Medical Innovations Holdings's address is: 5 Oppenheimer Street, Rehovot, Israel, 7670105 What is G Medical Innovations Holdings's ISIN number?
G Medical Innovations Holdings's international securities identification number is: KYG394622081